Bifunctional compounds capable of inducing degradation of polo-like kinase1
CA3328371A1Undetermined Publication Date: 2025-11-06CROSSFIRE ONCOLOGY BV
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3328371
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-29
- Filing Date
- 2025-04-29
- Publication Date
- 2025-11-06
Abstract
The present invention relates to bifunctional compounds capable of inducing degradation of Polo- like kinase 1 (PLK1) via ubiquitin proteasome pathway. More specifically, the invention relates to bifunctional compounds and conjugates derived thereof, along with processes to prepare the compounds or conjugates, uses thereof and methods for treating diseases through modulation of Polo-like kinase 1 (PLK1). Specifically, the invention relates to the use of the bifunctional compounds or conjugates in the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art
